Correspondence 0001213900-24-012725 from OS Therapies Inc (OSTX)
OS Therapies Inc
Date: Feb. 12, 2024 · CIK: 0001795091 · Accession: 0001213900-24-012725
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271034
Letter
February 12, 2024
VIA EDGAR AND ELECTRONIC MAIL
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Joe McCann, Esq.
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-271034)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statements to 5:00 p.m., Eastern time, on Wednesday, February 14, 2024, or as soon as practicable thereafter.
Please advise the undersigned of the effectiveness of the Registration Statements.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Jimmy McNamara, Esq.
Paul A. Romness, MPH
February 12, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Joe McCann, Esq.
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-271034)
Ladies and Gentlemen:
OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statements be accelerated so that they will become effective at 5:00 p.m., Eastern time, on Wednesday, February 14, 2024, or as soon as practicable thereafter.
Very truly yours,
OS Therapies Incorporated
Show Raw Text
CORRESP
1
filename1.htm
February 12, 2024
VIA EDGAR AND ELECTRONIC MAIL
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Joe McCann, Esq.
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-271034)
Ladies and Gentlemen:
On behalf of OS Therapies
Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced
Registration Statements to 5:00 p.m., Eastern time, on Wednesday, February 14, 2024, or as soon as practicable thereafter.
Please advise the undersigned
of the effectiveness of the Registration Statements.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Jimmy McNamara, Esq.
Paul A. Romness, MPH
February 12, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Joe McCann, Esq.
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-271034)
Ladies and Gentlemen:
OS Therapies Incorporated
hereby requests that the effectiveness of the above-referenced Registration Statements be accelerated so that they will become effective
at 5:00 p.m., Eastern time, on Wednesday, February 14, 2024, or as soon as practicable thereafter.
Very truly yours,
OS Therapies Incorporated
By:
/s/ Paul A. Romness
Paul A. Romness
President and Chief Executive Officer